So-Yeon Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
So-Yeon Park has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
- Jeong-Seok Nam
Department of Life Sciences, Gwangju Institute of Science and Technology, Gwangju, Republic of Korea
14 shared publications Min-Jin Kim
College of Pharmacy, Ewha Womans University, Seoul, Korea
6 shared publications- Yhun Yhong Sheen
College of Pharmacy, Ewha Womans University, Seoul, Republic of Korea
6 shared publications Dae-Kee Kim
5 shared publicationsSang-A Park
5 shared publicationsJung-Shin Kim
4 shared publications
Latest Publications
- Open Access
- 15 June 2026
- Published by Springer Nature in Signal Transduction and Targeted Therapy
- Vol. 11 (1) , 234
Targeting the senescence‒autophagy axis via p16INK4a inhibition alleviates pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease for which effective therapies are lacking. While cellular senescence and autophagy have been implicated in IPF pathogenesis, the intersecting mechanisms that drive fibrosis progression remain unclear. Our patient-derived transcriptomic analysis revealed a strong association between enhanced extracellular matrix remodeling, cellular senescence, and autophagic dysfunction in IPF. Among the potential driver genes associated with cellular senescence, the elevated expression of p16 INK4A (p16) is correlated with impaired autophagic flux in naturally aging mice, bleomycin (BLM)- and radiation-induced pulmonary fibrosis (PF) mouse models, and lung tissues from IPF patients. Genetic depletion of p16 reduced PF and preserved autophagic flux in response to fibrotic challenge, independent of p21 Cip1 . Applying this knowledge, we screened antifibrotic compounds from extracts of the medicinal fruit of Melia azedarach and identified toosendanin. This compound suppressed p16 promoter activity, effectively restored autophagic flux, and attenuated BLM-induced PF in vivo. We further showed that the p16 promoter inhibitor abyssinone II alleviated both autophagy dysfunction and fibrosis progression, whereas the promoter activator neorautenol exacerbated both phenotypes, demonstrating that p16 acts as a key regulatory node in the regulation of the crosstalk between senescence and autophagy dysfunction. Collectively, our results identify p16 as a mechanistically defined regulator of fibrosis progression and suggest that modulating this axis may offer new opportunities for therapeutic intervention in IPF.
- 15 June 2026
- Published by Springer Nature in Signal Transduction and Targeted Therapy
- Vol. 11 (1) , 234
Open AccessTargeting the senescence‒autophagy axis via p16INK4a inhibition alleviates pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease for which effective therapies are lacking. While cellular senescence and autophagy have been implicated in IPF pathogenesis, the intersecting mechanisms that drive fibrosis progression remain unclear. Our patient-derived transcriptomic analysis revealed a strong association between enhanced extracellular matrix remodeling, cellular senescence, and autophagic dysfunction in IPF. Among the potential driver genes associated with cellular senescence, the elevated expression of p16 INK4A (p16) is correlated with impaired autophagic flux in naturally aging mice, bleomycin (BLM)- and radiation-induced pulmonary fibrosis (PF) mouse models, and lung tissues from IPF patients. Genetic depletion of p16 reduced PF and preserved autophagic flux in response to fibrotic challenge, independent of p21 Cip1 . Applying this knowledge, we screened antifibrotic compounds from extracts of the medicinal fruit of Melia azedarach and identified toosendanin. This compound suppressed p16 promoter activity, effectively restored autophagic flux, and attenuated BLM-induced PF in vivo. We further showed that the p16 promoter inhibitor abyssinone II alleviated both autophagy dysfunction and fibrosis progression, whereas the promoter activator neorautenol exacerbated both phenotypes, demonstrating that p16 acts as a key regulatory node in the regulation of the crosstalk between senescence and autophagy dysfunction. Collectively, our results identify p16 as a mechanistically defined regulator of fibrosis progression and suggest that modulating this axis may offer new opportunities for therapeutic intervention in IPF.
- Open Access
- 12 March 2026
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 47 (4) , 403-422
Targeting the senescence–autophagy axis for idiopathic pulmonary fibrosis therapy
- 12 March 2026
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 47 (4) , 403-422
Open AccessTargeting the senescence–autophagy axis for idiopathic pulmonary fibrosis therapy
- Open Access
- 3 May 2024
- Published by Korean Society for Stem Cell Research in International Journal of Stem Cells
- Vol. 17 (4) , 337-346
Gastric Organoid, a Promising Modeling for Gastric Stem Cell Homeostasis and Therapeutic Application
Subin Lee, Jang-Hyun Choi, So-Yeon Park, Jihoon Kim. IJSC -0001;0:. https://doi.org/10.15283/ijsc23075
- 3 May 2024
- Published by Korean Society for Stem Cell Research in International Journal of Stem Cells
- Vol. 17 (4) , 337-346
Open AccessGastric Organoid, a Promising Modeling for Gastric Stem Cell Homeostasis and Therapeutic Application
Subin Lee, Jang-Hyun Choi, So-Yeon Park, Jihoon Kim. IJSC -0001;0:. https://doi.org/10.15283/ijsc23075
- 15 March 2023
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 665, 10-18
SEC22B inhibition attenuates colorectal cancer aggressiveness and autophagic flux under unfavorable environment
- 15 March 2023
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 665, 10-18
SEC22B inhibition attenuates colorectal cancer aggressiveness and autophagic flux under unfavorable environment
- Open Access
- 14 December 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (24) , 13413
The Small-Molecule Wnt Inhibitor ICG-001 Efficiently Inhibits Colorectal Cancer Stemness and Metastasis by Suppressing MEIS1 Expression
Recurrence and metastasis remain major obstacles in colorectal cancer (CRC) treatment. Recent studies suggest that a small subpopulation of cells with a self-renewal ability, called cancer stem-like cells (CSCs), promotes recurrence and metastasis in CRC. Unfortunately, no CSC inhibitor has been demonstrated to be more effective than existing chemotherapeutic drugs, resulting in a significant unmet need for effective CRC therapies. In this study, transcriptomic profiling of metastatic tumors from CRC patients revealed significant upregulation in the Wnt pathway and stemness genes. Thus, we examined the therapeutic effect of the small-molecule Wnt inhibitor ICG-001 on cancer stemness and metastasis. The ICG-001 treatment efficiently attenuated self-renewal activity and metastatic potential. Mechanistically, myeloid ecotropic viral insertion site 1 (MEIS1) was identified as a target gene of ICG-001 that is transcriptionally regulated by Wnt signaling. A series of functional analyses revealed that MEIS1 enhanced the CSC behavior and metastatic potential of the CRC cells. Collectively, our findings suggest that ICG-001 efficiently inhibits CRC stemness and metastasis by suppressing MEIS1 expression. These results provide a basis for the further clinical investigation of ICG-001 as a targeted therapy for CSCs, opening a new avenue for the development of novel Wnt inhibitors for the treatment of CRC metastasis.
- 14 December 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (24) , 13413
Open AccessThe Small-Molecule Wnt Inhibitor ICG-001 Efficiently Inhibits Colorectal Cancer Stemness and Metastasis by Suppressing MEIS1 Expression
Recurrence and metastasis remain major obstacles in colorectal cancer (CRC) treatment. Recent studies suggest that a small subpopulation of cells with a self-renewal ability, called cancer stem-like cells (CSCs), promotes recurrence and metastasis in CRC. Unfortunately, no CSC inhibitor has been demonstrated to be more effective than existing chemotherapeutic drugs, resulting in a significant unmet need for effective CRC therapies. In this study, transcriptomic profiling of metastatic tumors from CRC patients revealed significant upregulation in the Wnt pathway and stemness genes. Thus, we examined the therapeutic effect of the small-molecule Wnt inhibitor ICG-001 on cancer stemness and metastasis. The ICG-001 treatment efficiently attenuated self-renewal activity and metastatic potential. Mechanistically, myeloid ecotropic viral insertion site 1 (MEIS1) was identified as a target gene of ICG-001 that is transcriptionally regulated by Wnt signaling. A series of functional analyses revealed that MEIS1 enhanced the CSC behavior and metastatic potential of the CRC cells. Collectively, our findings suggest that ICG-001 efficiently inhibits CRC stemness and metastasis by suppressing MEIS1 expression. These results provide a basis for the further clinical investigation of ICG-001 as a targeted therapy for CSCs, opening a new avenue for the development of novel Wnt inhibitors for the treatment of CRC metastasis.
- Open Access
- 1 December 2020
- Published by MDPI AG in Biomedicines
- Vol. 8 (12) , 560
The Hippo–YAP Signaling as Guardian in the Pool of Intestinal Stem Cells
Despite endogenous insults such as mechanical stress and danger signals derived from the microbiome, the intestine can maintain its homeostatic condition through continuous self-renewal of the crypt–villus axis. This extraordinarily rapid turnover of intestinal epithelium, known to be 3 to 5 days, can be achieved by dynamic regulation of intestinal stem cells (ISCs). The crypt base-located leucine-rich repeat-containing G-protein-coupled receptor 5-positive (Lgr5+) ISCs maintain intestinal integrity in the steady state. Under severe damage leading to the loss of conventional ISCs, quiescent stem cells and even differentiated cells can be reactivated into stem-cell-like cells with multi-potency and contribute to the reconstruction of the intestinal epithelium. This process requires fine-tuning of the various signaling pathways, including the Hippo–YAP system. In this review, we summarize recent advances in understanding the correlation between Hippo–YAP signaling and intestinal homeostasis, repair, and tumorigenesis, focusing specifically on ISC regulation.
- 1 December 2020
- Published by MDPI AG in Biomedicines
- Vol. 8 (12) , 560
Open AccessThe Hippo–YAP Signaling as Guardian in the Pool of Intestinal Stem Cells
Despite endogenous insults such as mechanical stress and danger signals derived from the microbiome, the intestine can maintain its homeostatic condition through continuous self-renewal of the crypt–villus axis. This extraordinarily rapid turnover of intestinal epithelium, known to be 3 to 5 days, can be achieved by dynamic regulation of intestinal stem cells (ISCs). The crypt base-located leucine-rich repeat-containing G-protein-coupled receptor 5-positive (Lgr5+) ISCs maintain intestinal integrity in the steady state. Under severe damage leading to the loss of conventional ISCs, quiescent stem cells and even differentiated cells can be reactivated into stem-cell-like cells with multi-potency and contribute to the reconstruction of the intestinal epithelium. This process requires fine-tuning of the various signaling pathways, including the Hippo–YAP system. In this review, we summarize recent advances in understanding the correlation between Hippo–YAP signaling and intestinal homeostasis, repair, and tumorigenesis, focusing specifically on ISC regulation.
- Open Access
- 1 May 2020
- Published by Elsevier in EBioMedicine
- Vol. 55, 102762
Kynurenine pathway enzyme KMO in cancer progression: A tip of the Iceberg
- 1 May 2020
- Published by Elsevier in EBioMedicine
- Vol. 55, 102762
Open AccessKynurenine pathway enzyme KMO in cancer progression: A tip of the Iceberg
- Top Cited PapersOpen Access
- 11 September 2019
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 38 (1) , 1-18
The JAK2/STAT3/CCND2 Axis promotes colorectal Cancer stem cell persistence and radioresistance
Background: Radiotherapy (RT) is a highly effective multimodal nonsurgical treatment that is essential for patients with advanced colorectal cancer (CRC). Nevertheless, cell subpopulations displaying intrinsic radioresistance survive after RT. The reactivation of their proliferation and successful colonization at local or distant sites may increase the risk of poor clinical outcomes. Recently, radioresistant cancer cells surviving RT were reported to exhibit a more aggressive phenotype than parental cells, although the underlying mechanisms remain unclear. Methods: By investigating public databases containing CRC patient data, we explored potential radioresistance-associated signaling pathways. Then, their mechanistic roles in radioresistance were investigated through multiple validation steps using patient-derived primary CRC cells, human CRC cell lines, and CRC xenografts. Results: Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling was activated in radioresistant CRC tissues in correlation with local and distant metastases. JAK2 was preferentially overexpressed in the CRC stem cell subpopulation, which was accompanied by the phosphorylation of STAT proteins, especially STAT3. JAK2/STAT3 signaling played an essential role in promoting tumor initiation and radioresistance by limiting apoptosis and enhancing clonogenic potential. Mechanistically, the direct binding of STAT3 to the cyclin D2 (CCND2) promoter increased CCND2 transcription. CCND2 expression was required for persistent cancer stem cell (CSC) growth via the maintenance of an intact cell cycle and proliferation with low levels of DNA damage accumulation. Conclusion: Herein, we first identified JAK2/STAT3/CCND2 signaling as a resistance mechanism for the persistent growth of CSCs after RT, suggesting potential biomarkers and regimens for improving outcomes among CRC patients.
- 11 September 2019
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 38 (1) , 1-18
Top Cited PapersOpen AccessThe JAK2/STAT3/CCND2 Axis promotes colorectal Cancer stem cell persistence and radioresistance
Background: Radiotherapy (RT) is a highly effective multimodal nonsurgical treatment that is essential for patients with advanced colorectal cancer (CRC). Nevertheless, cell subpopulations displaying intrinsic radioresistance survive after RT. The reactivation of their proliferation and successful colonization at local or distant sites may increase the risk of poor clinical outcomes. Recently, radioresistant cancer cells surviving RT were reported to exhibit a more aggressive phenotype than parental cells, although the underlying mechanisms remain unclear. Methods: By investigating public databases containing CRC patient data, we explored potential radioresistance-associated signaling pathways. Then, their mechanistic roles in radioresistance were investigated through multiple validation steps using patient-derived primary CRC cells, human CRC cell lines, and CRC xenografts. Results: Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling was activated in radioresistant CRC tissues in correlation with local and distant metastases. JAK2 was preferentially overexpressed in the CRC stem cell subpopulation, which was accompanied by the phosphorylation of STAT proteins, especially STAT3. JAK2/STAT3 signaling played an essential role in promoting tumor initiation and radioresistance by limiting apoptosis and enhancing clonogenic potential. Mechanistically, the direct binding of STAT3 to the cyclin D2 (CCND2) promoter increased CCND2 transcription. CCND2 expression was required for persistent cancer stem cell (CSC) growth via the maintenance of an intact cell cycle and proliferation with low levels of DNA damage accumulation. Conclusion: Herein, we first identified JAK2/STAT3/CCND2 signaling as a resistance mechanism for the persistent growth of CSCs after RT, suggesting potential biomarkers and regimens for improving outcomes among CRC patients.
- Open Access
Targeting Cancer Stem Cells in Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is a highly aggressive form of breast cancer that lacks targeted therapy options, and patients diagnosed with TNBC have poorer outcomes than patients with other breast cancer subtypes. Emerging evidence suggests that breast cancer stem cells (BCSCs), which have tumor-initiating potential and possess self-renewal capacity, may be responsible for this poor outcome by promoting therapy resistance, metastasis, and recurrence. TNBC cells have been consistently reported to display cancer stem cell (CSC) signatures at functional, molecular, and transcriptional levels. In recent decades, CSC-targeting strategies have shown therapeutic effects on TNBC in multiple preclinical studies, and some of these strategies are currently being evaluated in clinical trials. Therefore, understanding CSC biology in TNBC has the potential to guide the discovery of novel therapeutic agents in the future. In this review, we focus on the self-renewal signaling pathways (SRSPs) that are aberrantly activated in TNBC cells and discuss the specific signaling components that are involved in the tumor-initiating potential of TNBC cells. Additionally, we describe the molecular mechanisms shared by both TNBC cells and CSCs, including metabolic plasticity, which enables TNBC cells to switch between metabolic pathways according to substrate availability to meet the energetic and biosynthetic demands for rapid growth and survival under harsh conditions. We highlight CSCs as potential key regulators driving the aggressiveness of TNBC. Thus, the manipulation of CSCs in TNBC can be a targeted therapeutic strategy for TNBC in the future.
Open AccessTargeting Cancer Stem Cells in Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is a highly aggressive form of breast cancer that lacks targeted therapy options, and patients diagnosed with TNBC have poorer outcomes than patients with other breast cancer subtypes. Emerging evidence suggests that breast cancer stem cells (BCSCs), which have tumor-initiating potential and possess self-renewal capacity, may be responsible for this poor outcome by promoting therapy resistance, metastasis, and recurrence. TNBC cells have been consistently reported to display cancer stem cell (CSC) signatures at functional, molecular, and transcriptional levels. In recent decades, CSC-targeting strategies have shown therapeutic effects on TNBC in multiple preclinical studies, and some of these strategies are currently being evaluated in clinical trials. Therefore, understanding CSC biology in TNBC has the potential to guide the discovery of novel therapeutic agents in the future. In this review, we focus on the self-renewal signaling pathways (SRSPs) that are aberrantly activated in TNBC cells and discuss the specific signaling components that are involved in the tumor-initiating potential of TNBC cells. Additionally, we describe the molecular mechanisms shared by both TNBC cells and CSCs, including metabolic plasticity, which enables TNBC cells to switch between metabolic pathways according to substrate availability to meet the energetic and biosynthetic demands for rapid growth and survival under harsh conditions. We highlight CSCs as potential key regulators driving the aggressiveness of TNBC. Thus, the manipulation of CSCs in TNBC can be a targeted therapeutic strategy for TNBC in the future.
- Open Access
- 25 July 2017
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 18 (8) , 1604
Roles of Wnt Target Genes in the Journey of Cancer Stem Cells
The importance of Wnt/β-catenin signaling in cancer stem cells (CSCs) has been acknowledged; however, the mechanism through which it regulates the biological function of CSCs and promotes cancer progression remains elusive. Hence, to understand the intricate mechanism by which Wnt controls stemness, the specific downstream target genes of Wnt were established by analyzing the genetic signatures of multiple types of metastatic cancers based on gene set enrichment. By focusing on the molecular function of Wnt target genes, the biological roles of Wnt were interpreted in terms of CSC dynamics from initiation to metastasis. Wnt signaling participates in cancer initiation by generating CSCs from normal stem cells or non-CSCs and augmenting persistent growth at the primary region, which is resistant to anti-cancer therapy. Moreover, it assists CSCs in invading nearby tissues and in entering the blood stream, during which the negative feedback of the Wnt signaling pathway maintains CSCs in a dormant state that is suitable for survival. When CSCs arrive at distant organs, another burst of Wnt signaling induces CSCs to succeed in re-initiation and colonization. This comprehensive understanding of Wnt target genes provides a plausible explanation for how Wnt allows CSCs variation during cancer progression.
- 25 July 2017
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 18 (8) , 1604
Open AccessRoles of Wnt Target Genes in the Journey of Cancer Stem Cells
The importance of Wnt/β-catenin signaling in cancer stem cells (CSCs) has been acknowledged; however, the mechanism through which it regulates the biological function of CSCs and promotes cancer progression remains elusive. Hence, to understand the intricate mechanism by which Wnt controls stemness, the specific downstream target genes of Wnt were established by analyzing the genetic signatures of multiple types of metastatic cancers based on gene set enrichment. By focusing on the molecular function of Wnt target genes, the biological roles of Wnt were interpreted in terms of CSC dynamics from initiation to metastasis. Wnt signaling participates in cancer initiation by generating CSCs from normal stem cells or non-CSCs and augmenting persistent growth at the primary region, which is resistant to anti-cancer therapy. Moreover, it assists CSCs in invading nearby tissues and in entering the blood stream, during which the negative feedback of the Wnt signaling pathway maintains CSCs in a dormant state that is suitable for survival. When CSCs arrive at distant organs, another burst of Wnt signaling induces CSCs to succeed in re-initiation and colonization. This comprehensive understanding of Wnt target genes provides a plausible explanation for how Wnt allows CSCs variation during cancer progression.